An Activin A/BMP2 chimera, AB215, blocks estrogen signaling via induction of ID proteins in breast cancer cells. [electronic resource]
Producer: 20150407Description: 549 p. digitalISSN:- 1471-2407
- Activins -- pharmacology
- Bone Morphogenetic Protein 2 -- pharmacology
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Estrogen Receptor alpha -- metabolism
- Female
- Humans
- Inhibitor of Differentiation Proteins -- genetics
- MCF-7 Cells
- Neoplasm Transplantation
- Recombinant Fusion Proteins -- pharmacokinetics
- Signal Transduction -- drug effects
- Tamoxifen -- therapeutic use
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.